SCHEMBL8116641

SCHEMBL8116641

CC[C@@H]1CN(C(=O)OCc2ccccc2)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.63
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
OPRK1 P41145 1/20 0.47
HTT P42858 1/20 0.47
NR1H2 P55055 2/20 0.46
NR1H3 Q13133 2/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KAT7 O95251 1/20 0.44
ABHD6 Q9BV23 1/20 0.44
DAGLA Q9Y4D2 1/20 0.44
JAK2 O60674 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30440068 1.00 PARP1 (0.63) PARP1PDK1PDK2PDK3PDK4
SCHEMBL38665073 0.96 PARP1 (0.58) PARP1PDK1PDK2PDK3PDK4
SCHEMBL19959259 0.96 PARP1 (0.58) PARP1PDK1PDK2PDK3PDK4
SCHEMBL20139814 0.94 PARP1 (0.59) PARP1PDK1PDK2PDK3PDK4
SCHEMBL20139812 0.94 PARP1 (0.59) PARP1PDK1PDK2PDK3PDK4
SCHEMBL23366073 0.94 PARP1 (0.59) PARP1PDK1PDK2PDK3PDK4
SCHEMBL8121116 0.91 PARP1 (0.61) PARP1PDK1PDK2PDK3PDK4
SCHEMBL20129602 0.91 PARP1 (0.63) PARP1PDK1PDK2PDK3PDK4
SCHEMBL6334954 0.91 PARP1 (0.63) PARP1PDK1PDK2PDK3PDK4
SCHEMBL2420439 0.91 PARP1 (0.63) PARP1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008139941-A1 SUBSTITUTED IMIDAZOLE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-20 WO disclosed